Intergen

Intergen (İntergen) is a Turkish genetic diagnostics and rare disease research center headquartered in Ankara, Turkey. Founded in 1999, the institution describes itself as operating on principles that value "humanity, health, and science," and has since grown into one of the world's leading centers for genetic test variety. According to its official website, Intergen designs approximately 90% of its tests in-house using its own research and development infrastructure, and its genetic test portfolio includes more than 5,500 genetic tests. The center positions itself as a pioneer in diagnosing undiagnosed diseases and developing diagnostic and treatment approaches for genetic disorders, including very rare conditions. Intergen's activities span clinical genetic testing, research and development, education, and scientific publishing. The organization states that it has participated in more than 100 scientific projects and produced over 250 international publications, and that it has received innovation awards. It also runs educational programs, sharing its experience of more than 25 years with those who seek it. The center reports that it spends most of its revenue on research and has been ranked among Turkey's top 500 companies by R&D investment for several years, rising in the rankings each year. It has also established an institute dedicated to science, human health, and education, which it continues to grow. Intergen is involved in international organizations focused on rare and undiagnosed diseases, in some cases at a managerial level, and seeks to shape global policies in this field. Its clinical team publishes blog articles and educational content, and the website features patient testimonials. The organization's stated mission is to spread awareness of rare diseases in Turkey and worldwide and to alleviate the burden these conditions place on patients, their loved ones, and the country. The company is headquartered in Ankara and operates primarily in Turkey while engaging with international partners and networks.

Intergen was founded in 1999 in Ankara, Turkey, with the stated principles of valuing "humanity, health, and science." From its early years, the organization focused on developing patient-specific tests even for a single patient, and on participating in efforts to diagnose and develop treatments for genetic diseases. Over the following decades, it built an extensive portfolio of genetic tests, reaching more than 5,500 tests, approximately 90% of which it designed in-house using its own R&D infrastructure. The center has positioned itself at the forefront of rare and undiagnosed disease diagnostics in Turkey. It reports having discovered many new disease types and conducted diagnostic studies for very rare conditions. Its scientific output includes participation in more than 100 projects and more than 250 international publications, as well as innovation awards. Intergen has also been recognized among Turkey's top 500 companies by R&D investment for multiple years, with its ranking improving annually, and it spends most of its revenue on research. Beyond diagnostics, Intergen has invested in education, sharing its experience of more than 25 years through training programs, and has established an institute dedicated to science, human health, and education. It is active in international organizations focused on rare and undiagnosed diseases, sometimes at a managerial level, and aims to influence global policies in this area. The organization continues to operate from its headquarters in Ankara, serving patients in Turkey and collaborating internationally.

• 1999

  Intergen founded in Ankara, Turkey, with principles valuing humanity, health, and science.

• Genetic test portfolio grows to over 5,500 tests, with approximately 90% designed in-house.

• Participates in more than 100 scientific projects and publishes over 250 international papers.

• Ranked among Turkey's top 500 companies by R&D investment for multiple years.

• Establishes an institute dedicated to science, human health, and education.

A research-driven genetic diagnostics center specializing in rare and undiagnosed diseases, with a strong emphasis on in-house R&D and scientific contribution.

• Genetic test portfolio (5,500+ tests)

  Comprehensive range of genetic tests, approximately 90% developed in-house.

• Rare disease diagnostic testing

  Diagnostic studies for very rare diseases, including discovery of new disease types.

• Undiagnosed disease testing

  Programs aimed at diagnosing conditions that have remained undiagnosed.

• Patient-specific test development

  Development of custom tests even for a single patient.

• Embryo selection / preimplantation genetic testing

  Assisted reproductive genetic testing, as mentioned in patient testimonials.

1. 1INTERGEN Genetik ve Nadir Hastalıklar Tanı Araştırma & Uygulama Merkeziintergen.com.tr
2. 2About Us | İNTERGENintergen.com.tr
3. 3Intergen (Turkey) - Wikidatawikidata.org